GlobalData Healthcare

Unlocking Growth Potential: PCR Systems Market Report 2023-2033 📈! Dive into the $700.3M market with a promising CAGR of 5% 🔍. PCR Systems, the backbone of nucleic acid amplification, are indispensable in cancer and infectious disease diagnostics 🩺. Explore market segments, share insights and regulatory updates 📊. https://lnkd.in/gADmDAMX #medicaldevices #pcr #cagr #PCRSystems #HealthcareTech #Innovation

🔍 Explore the future of ophthalmology with our latest report! 🌟 Dive into the $46 million CGT market in 2023, poised for moderate growth. 📈 Discover how gene therapies for LCA and retinitis are shaping the industry. 💡 Gain insights into launch dates, clinical trials, and market forecasts. Also includes an outlook on pricing, reimbursement, and regulatory landscapes. 🚀 Explore more: https://lnkd.in/guV-mRFU #Ophthalmology #GeneTherapies #Innovation #HealthcareTech

Innovative #FDA drug approvals rocket over the past year. Our latest report dives into opportunities for CMOs, drug shortages, and supply chain security. Find out more: https://lnkd.in/ebc_gTct Client link: https://lnkd.in/eG8-NVdJ #pharmaceuticals #FDA

🌟 Unlock the power of patient empowerment with our latest report! 🌟 Gain insights into patients' health literacy and interactions with healthcare professionals. 🩺 Discover what patients truly think about empowerment in healthcare and the dynamics of shared decision-making. 💬 Evaluate access to crucial disease and treatment information, and delve into the pivotal role of pharmaceutical companies in patient empowerment. 💊 https://lnkd.in/dtNjVPsK #pharma #healthcare #patients #patientempowerment 

Exciting news! The Immunochemistry Analyzers Market is booming 💥 with a value of $1.41 billion in 2023 📈. Forecasted to grow at over 4% CAGR until 2033 🌱, these analyzers are essential for infectious diagnostics, protein tests, and drug analysis 🧪. With modular options allowing independent or simultaneous operation, they offer flexibility and efficiency 🔄. Stay ahead in the healthcare game with the latest in immunochemistry technology! https://lnkd.in/gF7yCWjk #medical #healthcare #HealthcareInnovation #MedicalTechnology

Did you see our Senior Director, Amanda Murphy at #CTSNE24 last week? She had the pleasure of chairing the event, moderating panels and presenting on the ‘State of the Biopharmaceutical Industry’, and of course, meeting lots of attendees. Amanda’s key takeaway from the event was how “a common theme was the close lens on carbon footprints and net zero within our industry”. If you would like to see Amanda’s slides from the event, reply ‘yes’ in the comments and we will get in touch. Thank you, Arena International Events Group, for another great event! 

🔍 Excited to share insights from our latest report on Antibody-Drug Conjugates (ADC)! Dive into the competitive landscape of leading ADCs in oncology with SWOT analysis, clinical benchmark comparisons, and analyst consensus forecasts. 💡 Gain valuable perspectives from key opinion leaders and explore opportunities and challenges in the space. 🚀 Stay ahead with commentary on the latest trends in ADC development, including payload and linker analysis. https://lnkd.in/gBCz_qVy #ADC #Oncology #Pharma #Innovation 

Subscribe to #DECODED for expert #healthcare industry insights, forecasts, and opinions from leading journalists & best-in-class datasets. 💡 Sign-up now:

📊 Dive into our latest 'Obesity' market report to uncover trends and analysis: 🔍 Understand the epidemiology, symptoms, diagnosis, and management for a holistic market overview. 💰 Forecasted annualized market revenue, therapy costs, and treatment patterns until 2031. 🔑 Explore strategic competitor assessment, market characterization, and unmet needs. 🔬 Discover emerging trends and mechanisms of action for obesity treatment. 🌍 Analyze global market competition now and in the future. 🧠 Gain insights into industry drivers, restraints, and challenges. Explore more here: https://lnkd.in/gCQntfHx #healthcare #diagnosis #Obesity #Healthcare #Innovation

🚨 Legal Action Alert! 🚨 Bausch Health Companies Inc. and Salix Pharmaceuticals, Inc. are taking a stand against Amneal Pharmaceuticals with a lawsuit filed in the U.S. District Court for the District of New Jersey. 💼 Why? Amneal's Abbreviated New Drug Application (ANDA) for a generic version of XIFAXAN (rifaximin) 550 mg tablets has triggered a response. Bausch Health asserts the importance of protecting its XIFAXAN franchise, standing firm on its intellectual property rights. 💪 Thomas J. Appio, CEO of Bausch Health, reaffirms the company's confidence in XIFAXAN's intellectual property, stressing its critical role in continuing to deliver innovative therapies for patients. 🌟 This isn't the first rodeo for Bausch Health. Previous Paragraph IV Certifications from Teva Pharmaceuticals, Sandoz Inc., Sun Pharmaceuticals, and Norwich Pharmaceuticals have been dealt with through settlements and ongoing litigation. 🔍 XIFAXAN® (rifaximin) 550 mg tablets aren't just any medication - they're vital for reducing the risk of hepatic encephalopathy recurrence and treating irritable bowel syndrome with diarrhea in adults. 🩺 📊 GlobalData analysis from the Patent Analytics tool shows the key players with publications to treat Hepatic Encephalopathy. ⚡Connect with us today to explore the endless possibilities and propel your business forward! 📧 patents@globaldata.com or ☎ explore more at our contact page: https://lnkd.in/ggfMtshS #patents #healthcare #pharma #pharmaceuticals #health